Clinical Trial Update: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of amifostine for gynecologic cancers has been terminated (including ovarian, primary peritoneal, fallopian tube, cervical, uterine, and endometri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Uterine Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer, Endometrial Cancer | Phase 2 | Status: TERMINATED